Lanean...
Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
BACKGROUND & AIMS: Antiviral treatment is known to improve survival in patients with chronic hepatitis B (CHB)-related hepatocellular carcinoma (HCC). Yet, the treatment uptake in CHB patients remains low. We aimed to report the secular trend in antiviral treatment uptake from 2007–2017, and to...
Gorde:
| Argitaratua izan da: | JHEP Rep |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7530304/ https://ncbi.nlm.nih.gov/pubmed/33024950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2020.100152 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|